BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28708214)

  • 1. Hypomagnesemia and cause-specific mortality in hemodialysis patients: 5-year follow-up analysis.
    Selim GN; Spasovski G; Tozija L; Georgievska-Ismail L; Zafirova-Ivanovska B; Masin-Spasovska J; Rambabova-Busletic I; Petronijevic Z; Dzekova-Vidimliski P; Ristovska V; Pusevski V; Stojceva-Taneva O
    Int J Artif Organs; 2017 Oct; 40(10):542-549. PubMed ID: 28708214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Serum Magnesium Level and Its Variability in Maintenance Hemodialysis Patients: Associations with Mortality.
    Wu L; Cai K; Luo Q; Wang L; Hong Y
    Kidney Blood Press Res; 2019; 44(2):222-232. PubMed ID: 30921805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Mortality in Maintenance Haemodialysis Patients on High versus Low Dialysate Magnesium: A Pilot Study.
    Schmaderer C; Braunisch MC; Suttmann Y; Lorenz G; Pham D; Haller B; Angermann S; Matschkal J; Renders L; Baumann M; Braun JR; Heemann U; Küchle C
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28832502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomagnesemia is not an independent risk factor for mortality in Japanese maintenance hemodialysis patients.
    Mizuiri S; Nishizawa Y; Yamashita K; Naito T; Ono K; Tanji C; Usui K; Doi S; Masaki T; Shigemoto K
    Int Urol Nephrol; 2019 Jun; 51(6):1043-1052. PubMed ID: 30977017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypomagnesemia Is a Risk Factor for Cardiovascular Disease- and Noncardiovascular Disease-Related Mortality in Peritoneal Dialysis Patients.
    Zhang F; Wu X; Wen Y; Zhan X; Peng FF; Wang X; Qian Z; Feng X
    Blood Purif; 2022; 51(1):23-30. PubMed ID: 33882494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study.
    Lacson E; Wang W; Ma L; Passlick-Deetjen J
    Am J Kidney Dis; 2015 Dec; 66(6):1056-66. PubMed ID: 26190226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic role of brain natriuretic peptides in hemodialysis patients.
    Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T
    Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients.
    Yamashita K; Mizuiri S; Nishizawa Y; Shigemoto K; Doi S; Masaki T
    Ther Apher Dial; 2018 Feb; 22(1):31-39. PubMed ID: 28971590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined index of cardiac biomarkers as a risk factor for early cardiovascular mortality in hemodialysis patients.
    Bargnoux AS; Morena M; Jaussent I; Maurice F; Chalabi L; Leray-Moragues H; Terrier N; Dupuy AM; Badiou S; Canaud B; Cristol JP
    Clin Chem Lab Med; 2013 Sep; 51(9):1865-74. PubMed ID: 23399590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients.
    Merle E; Roth H; London GM; Jean G; Hannedouche T; Bouchet JL; Drüeke T; Fouque D; Daugas E;
    Kidney Int; 2016 Mar; 89(3):666-74. PubMed ID: 26880460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.
    Hayashi T; Kimura T; Yasuda K; Sasaki K; Obi Y; Rakugi H; Isaka Y
    Clin Exp Nephrol; 2017 Apr; 21(2):333-341. PubMed ID: 27178276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort.
    Sasaki K; Shoji T; Kabata D; Shintani A; Okute Y; Tsuchikura S; Shimomura N; Tsujimoto Y; Nakatani S; Mori K; Shioi A; Inaba M; Emoto M
    J Atheroscler Thromb; 2021 Mar; 28(3):249-260. PubMed ID: 32741893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study.
    Ago R; Shindo T; Banshodani M; Shintaku S; Moriishi M; Masaki T; Kawanishi H
    Hemodial Int; 2016 Oct; 20(4):580-588. PubMed ID: 27329549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients.
    Obokata M; Negishi K; Sunaga H; Ishida H; Ito K; Ogawa T; Iso T; Ando Y; Kurabayashi M
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Magnesium and Mortality in Maintenance Hemodialysis Patients.
    Yu L; Li H; Wang SX
    Blood Purif; 2017; 43(1-3):31-36. PubMed ID: 27875816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients.
    Ishimura E; Okuno S; Yamakawa T; Inaba M; Nishizawa Y
    Magnes Res; 2007 Dec; 20(4):237-44. PubMed ID: 18271493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
    Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study.
    Schneider A; Jardine AG; Schneider MP; Holdaas H; Holme I; Fellstroem BC; Zannad F; Schmieder RE;
    Am J Nephrol; 2013; 37(2):144-51. PubMed ID: 23392089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.